An N,N-Bis(benzimidazolylpicolinoyl)piperazine (BT-11): A Novel Lanthionine Synthetase C-Like 2-Based Therapeutic for Inflammatory Bowel Disease
Author:
Affiliation:
1. Biotherapeutics Inc., 1800 Kraft Drive, Suite 200, Blacksburg, Virginia 24060, United States
2. Georgetown University Medical Center, Washington, District of Columbia 20057, United States
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00412
Reference36 articles.
1. Interleukin-4 hyporesponsiveness in inflammatory bowel disease: Immune defect or physiological response?
2. Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments
3. Glucocorticosteroids Inhibit Leukotriene Production
4. Future directions in inflammatory bowel disease management
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery and Optimization of Novel Nonbile Acid FXR Agonists as Preclinical Candidates for the Treatment of Inflammatory Bowel Disease;Journal of Medicinal Chemistry;2024-03-28
2. Nuclear transport of phosphorylated LanCL2 promotes invadopodia formation and tumor progression of glioblastoma by activating STAT3/Cortactin signaling;Journal of Advanced Research;2024-03
3. New Insights into the LANCL2-ABA Binding Mode towards the Evaluation of New LANCL Agonists;Pharmaceutics;2023-12-12
4. Treating Autoimmune Diseases With LANCL2 Therapeutics: A Novel Immunoregulatory Mechanism for Patients With Ulcerative Colitis and Crohn’s Disease;Inflammatory Bowel Diseases;2023-11-02
5. Chemistry and biology of enzymes in protein glutathionylation;Current Opinion in Chemical Biology;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3